OOIR: Observatory of International Research

Papers

(The median citation count of Cancer Science is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Issue Information	132
Issue Information	110
Issue Information	108
Identification of sequence polymorphism in the D‐loop region of mitochondrial DNA as a risk factor for breast cancer	100
A Contrast‐Enhanced Ultrasound Cine‐Based Deep Learning Model for Predicting the Response of Advanced Hepatocellular Carcinoma to Hepatic Arterial Infusion Chemotherapy Combined With Systemic Therapie	99
Efficacy and biomarker analysis of second‐line nab‐paclitaxel plus sintilimab in patients with advanced biliary tract cancer	94
Emergence of PALB2 Reversion Mutations as a Mechanism of Resistance to Niraparib in Breast Cancer:	76
PBK Expression Promotes the Aggressive Phenotypes of Mesothelioma	74
LHPP‐P38 MAPK/ERK‐ETS1 Axis Negative Feedback Signaling Restrains Progression in Breast Cancer	62
	58
Induction of immunogenic cell death in murine colon cancer cells by ferrocene‐containing redox phospholipid polymers	58
PHAX enhanced LIN28B‐mediated PBX3 mRNA stability to promote esophageal cancer development	56
EGFR inhibition in EGFR‐mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment	55
Limb expression 1‐like protein promotes epithelial–mesenchymal transition and epidermal growth factor receptor‐tyrosine kinase inhibitor resistance via nucleolin‐mediated ribosomal RNA synt	54
FB23 ‐2 and Cisplatin Synergize to Inhibit Head and Neck Squamous Cell Carcinoma by Targeting the XPF /	54
Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors	52
Expression of Concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐depend	52
Correction to “ ELF3 ‐ AS1 contributes to gastric cancer progression by binding to	51
Correction to “Expression of concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML	47
Retraction	46
Prognostic and Predictive Value of Machine Learning‐Based Biomarker and Pathomics Signatures in Patients With Prostate Cancer	45
Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders	45
Tumor Endothelial Cells Induce M2 Macrophage Polarization via IL ‐4, Enhancing Tumor Growth in Hep	45
Genotype–Phenotype Correlations of Li–Fraumeni Syndrome in Japan Children's Cancer Group LFS20 Study Cohort	44
Reviewers	44

A Multicenter Phase II Trial of Nimustine Hydrochloride Administered via Convection‐Enhanced Delivery in Children With DIPG	43
Genome‐wide loss‐of‐function genetic screen identifies INSIG2 as the vulnerability of hepatitis B virus‐integrated hepatoma cells	41
GGCT Inhibits Ferroptosis in PTC Cells by Upregulating p53 Through RPS15A	40
	38
Comparison of ¹¹C‐Acetate and ¹⁸F‐FDG PET/CT for Immune Infiltration and Prognosis in Hepatocellular Carcinoma	38
Orthotopic Esophageal Cancer Xenograft Model in Immunosuppressed Microminipigs for Near‐Infrared Fluorescence Endoscopy	38
Novel and efficient method for culturing patient‐derived gastric cancer stem cells	38
Susceptibility of Brca1^(L63X/+) rat to ovarian reserve dissipation by chemotherapeutic agents to breast cancer	38
Trends in incidence and overdiagnosis of thyroid cancer in China, Japan, and South Korea	38
Interleukin‐4 induced 1‐mediated resistance to an immune checkpoint inhibitor through suppression of CD8⁺ T cell infiltration in melanoma	37
Formin‐like 2 promotes angiogenesis and metastasis of colorectal cancer by regulating the EGFL6/CKAP4/ERK axis	37
Epidemiology of skin cancer based on Japan's National Cancer Registry 2016–2017	36
Tumor exosomal RNPEP promotes lung metastasis of liver cancer via inducing cancer‐associated fibroblast activation	36
Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma	36
Methyltransferase‐like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6‐methyladenosine‐dependent manner	36
The emerging multifaceted role of PINK1 in cancer biology	35
Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypes	35
Effectiveness and Safety of Radium‐223 for Bone‐Metastatic Castration‐Resistant Prostate Cancer: The KYUCOG ‐1901 Study	35
Novel CHI3L1‐Associated Angiogenic Phenotypes Define Glioma Microenvironments: Insights From Multi‐Omics Integration	34
Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9	34
Heterogeneity of Cellular Senescence: Subtype‐Specific Mechanisms and the Emerging Role of Plasma Membrane Damage	34
TGF‐β signaling promotes desmoid tumor formation via CSRP2 upregulation	34
Head and Neck Cancer Immunotherapy: Overcoming Limitations and Enhancing Efficacy	34
PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT/mTOR signaling pathway	34
Real‐World Data Analysis of Genomic Alterations Detected by a Dual DNA–RNA Comprehensive Genomic Profiling Test	33
In this issue	33
PEGylated Chitosan Nanoparticles: Engineering Multifunctional Platforms for Targeted Cervical and Lung Cancer Treatment	33
Issue Information	33
Histological diagnostic discrepancy and its clinical impact in bone and soft tissue tumors referred to a sarcoma center	33
Issue Information	32
	32
In This Issue	32
When and how should next‐generation sequencing and comprehensive genomic profiling assays be performed?	31
Concerning trends and potential issues in osteosarcoma research publication	30
The oncogenic driving force of CD30 signaling‐induced chromosomal instability in adult T‐cell leukemia/lymphoma	29
Distribution of Ectopic Germinal Centers in Thymic Epithelial Tumors and Their Relationship With Thymic Involution	29
Chronological improvement in precision oncology implementation in Japan	29
Prognostic impact of the presence or absence of prior cancer in patients with cancer using cure models: A population‐based study	29
Promotion of squamous cell carcinoma tumorigenesis by oncogene‐mediated THG‐1/TSC22D4 phosphorylation	29
Issue Information	29
Inhibition of the bone morphogenetic protein pathway suppresses tumor growth through downregulation of epidermal growth factor receptor in MEK/ERK‐dependent colorectal cancer	29
Serial comprehensive genomic profiling by next‐generation sequencing for patients with metastatic colorectal cancer	29
Personalized medicine with germline pathogenic variants: Importance of population‐ and region‐wide evidence	29
Genotype–phenotype correlation for extracolonic aggressive phenotypes in patients with familial adenomatous polyposis	28
Canonical and Non‐Canonical Functions of Histone H3K4 Methylation Modifiers in Cancer	28
Pleckstrin‐2‐promoted PPM1B degradation plays an important role in transforming growth factor‐β‐induced breast cancer cell invasion and metastasis	28
Lysyl oxidase‐like 2 promotes stemness and enhances antitumor effects of gefitinib in head and neck cancer via IFIT1 and IFIT3	28
A gain‐of‐function mutation in microRNA 142 is sufficient to cause the development of T‐cell leukemia in mice	28
Tumor‐Derived Extracellular Vesicles in Plasma for Predicting Anti‐ PD ‐1 Antibody Efficacy in Non‐Small Cell Lung Cancer	28
Abstracts	28

Correction to “G protein pathway suppressor 2 suppresses gastric cancer by destabilizing epidermal growth factor receptor”	27
Docetaxel‐Induced Immune Activation Shows Antitumor Synergy With the Tumor‐Targeted CD40 Agonist KK2269	27
Metformin inhibits the proliferation and invasion of ovarian cancer cells by suppressing tripartite motif‐containing 37‐induced tumor necrosis factor receptor‐associated factor 2 ubiquitination	27
Survival rate prediction of nasopharyngeal carcinoma patients based on MRI and gene expression using a deep neural network	27
Final Analysis of Neoadjuvant Sintilimab Plus Chemotherapy in IB – IIIA Non‐Small‐Cell Lung Cancer	27
CD90 Promotes Gastric Cancer Progression by Regulating SLC1A5 ‐Mediated Glutamine Metabolism Through	27
Multiplex plasma protein assays as a diagnostic tool for lung cancer	27
JI ‐ CJ002 and Dabrafenib Combination Enhances Antitumor Activity in Melanoma Associated With the Downregulation of	27
HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer	27
Correction	27
ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy	27
New Treatment Strategy and Future Research Direction for BRAF ‐Mutated Cancer	26
LRRC75A‐AS1 delivered by M2 macrophage exosomes promotes cervical cancer progression via enhancing SIX1 expression	26
Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis	26
Diversity of U1 Small Nuclear RNAs and Diagnostic Methods for Their Mutations	26
Carbon ion radiotherapy with pencil beam scanning for hepatocellular carcinoma: Long‐term outcomes from a phase I trial	26
Neoadjuvant nivolumab plus chemotherapy in resectable non‐small‐cell lung cancer in Japanese patients from CheckMate 816	26
CDX2 Promoter‐Controlled Oncolytic Adenovirus Suppresses Tumor Growth and Liver Metastasis of Colorectal Cancer	26
Targeting the NR3C1 ‐ ACSL4 Axis Triggers Ferroptosis to Overcome Radioresistance in Prostate Canc	26
Hepatic stellate cell‐released CXCL1 aggravates HCC malignant behaviors through the MIR4435‐2HG/miR‐506‐3p/TGFB1 axis	25
Effect of fasting on cancer: A narrative review of scientific evidence	25
NFATc4 Promotes Lung Adenocarcinoma Progression via the CCNB1/CDK1 Pathway and Is a Potential Prognostic Biomarker	25
Gut microbiome as a biomarker for predicting early recurrence of HBV‐related hepatocellular carcinoma	25
ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP‐2 signaling	25
	25
Rafoxanide negatively modulates STAT3 and NF‐κB activity and inflammation‐associated colon tumorigenesis	25
Carbonic Anhydrase 12 as a Novel Prognostic Biomarker and Therapeutic Target for High‐Risk Follicular Thyroid Carcinoma	25
In this issue	25
Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (	24
Phase I trial of apatinib and paclitaxel+oxaliplatin+5‐FU/levoleucovorin for treatment‐naïve advanced gastric cancer	24
Circulating cancer‐associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer	24
Intraperitoneal transfer of microRNA‐29b‐containing small extracellular vesicles can suppress peritoneal metastases of gastric cancer	23
Clinical Application of In‐House Comprehensive Genomic Profiling for Thoracic Cancer: Insights From a Japanese Hospital	23
	22
In This Issue	22
Efficacy and Safety of T‐ DXd in HER2 + and Low/Zero Metastatic BCBM	22
Methyltransferase like‐14 suppresses growth and metastasis of non‐small‐cell lung cancer by decreasing LINC02747	22
Body mass index and esophageal and gastric cancer: A pooled analysis of 10 population‐based cohort studies in Japan	22
BBOX1‐AS1 promotes gastric cardia adenocarcinoma progression via interaction with CtBP2 to facilitate the epithelial–mesenchymal transition process	22
Rev1 overexpression accelerates N‐methyl‐N‐nitrosourea (MNU)‐induced thymic lymphoma by increasing mutagenesis	22
Growth pattern of de novo small clusters of colorectal cancer is regulated by Notch signaling at detachment	22
Novel specific anti‐ESM1 antibodies overcome tumor bevacizumab resistance by suppressing angiogenesis and metastasis	22
From Genomic and Epigenomic Maps to Medicines in Adult T‐Cell Leukemia/Lymphoma	22
	21
CD44v5 domain regulates crosstalk between TNBC cells and tumor‐associated macrophages by enhancing the IL‐4R/STAT3 axis	21
Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK‐rearranged non‐small cell lung cancer	21
A Robust Immunohistochemistry‐Based Classification for BRAF V600E ‐Mutant Colorectal Cancer With Clinical Implications	21
Fibrocytes in tumor microenvironment: Identification of their fraction and novel therapeutic strategy	21
N6 ‐Methyladenosine‐Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the	21
Utility of Urinary Extracellular Vesicles for Colorectal Cancer: Comparison of DNA Quality and MRD Detection	21
Ezh2 Inhibits the Differentiation of Short‐Lived Effector CD8 ⁺ T Cells and Promotes T Cell‐Dependent Antitumor Immuni	21
Association between adherence to Eat‐Lancet diet and incidence and mortality of lung cancer: A prospective cohort study	21
Transferrin Receptor Promotes Endometrial Cancer Proliferation by Activating the Iron‐Dependent PI3K/AKT/mTOR Signaling Pathway	21
Cholesterol synthesis is essential for the growth of liver metastasis‐prone colorectal cancer cells	20
HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer	20
Neon ion (²⁰Ne¹⁰⁺) charged particle beams manipulate rapid tumor reoxygenation in syngeneic mouse models	20
	20
Correction to Circular RNA hsa_circ_001895 serves as a sponge of microRNA ‐296‐5p to promote clear	20
Evaluating the effect of childhood sunburn on the risk of cutaneous melanoma through Mendelian randomization	20
M2‐like tumor‐associated macrophages promote epithelial–mesenchymal transition through the transforming growth factor β/Smad/zinc finger e‐box binding homeobox pathway with increased metastatic potent	20
	20
Single‐Cell RNA ‐Seq Reveals the Effect of Commensal Bacteria on the Multistep Development of Esophageal Cancer	20
Abstracts	20
In this issue	20
Molecular subtyping of small‐cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies	20
Impact of Minimal Residual Disease on Early Recurrence of Liver Metastatic Colorectal Cancer	20
	20
In This Issue	20
Attitudes toward cancer screening in regional Japan during the COVID‐19 pandemic: An anonymous survey	19
Molecular and Cell Biological Characterization of Patient‐Derived Head and Neck Squamous Carcinoma Cell Lines	19
Carbon‐ion radiotherapy for oligometastatic liver disease: A national multicentric study by the Japan Carbon‐Ion Radiation Oncology Study Group (J‐CROS)	19
Immunoglobulin‐like transcript 2 blockade restores antitumor immune responses in glioblastoma	19
Incidence and risk factors for venous thromboembolism, bleeding, and death in colorectal cancer (Cancer‐VTE Registry)	19
Super‐Enhancer Formation in Scirrhous Gastric CAFs , and the Presence of a Stromal Field in Non‐Cancerous Tissues	19
Discovery‐Replication Strategy Identifies Serum Metabolite Biomarkers for Colorectal Cancer in a Chinese Cohort	19
Incidence of second primary cancers among survivors of childhood cancer: A population‐based study, Osaka, Japan, 1975–2015	19
Dysfunction of CD8⁺ T cells around tumor cells leads to occult lymph node metastasis in NSCLC patients	19
Role of catecholamine synthases in the maintenance of cancer stem‐like cells in malignant peripheral nerve sheath tumors	19
Mutation Analysis of TMB‐High Colorectal Cancer: Insights Into Molecular Pathways and Clinical Implications	19
PSMD14/E2F1 Axis‐Mediated CENPF Promotes the Metastasis of Triple‐Negative Breast Cancer Through Inhibiting Ferroptosis	19

Metabolism score and machine learning models for the prediction of esophageal squamous cell carcinoma progression	19
Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer‐associated fibroblast	19
Fibrous corona is reduced in cancer cell lines that attenuate microtubule nucleation from kinetochores	19
SIRT7 promotes Hippo/YAP activation and cancer cell proliferation in hepatocellular carcinoma via suppressing MST1	19
In Vitro Expansion and Transduction of Primary NK Cells Using Feeder Cells Expressing Costimulatory Molecules and IL‐21	19
The Sparing Effect of Multibeam Ultra‐High Dose‐Rate Irradiation on Intestinal Tissue in Mice	19
	19
GADD45β‐MTK1 signaling axis mediates oncogenic stress‐induced activation of the p38 and JNK pathways	19
Durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non–small‐cell lung cancer (NEJ056)	19
Comprehensive Colorectal Cancer Stem Cell Transcriptomic Signatures That Can Predict Patient Prognostic Outcomes	18
Evans Blue Acts as a Selective Inhibitor of CaMKII‐α to Impede the Progression of TCL Identified by HTS	18
Changes in survival of patients with non–small cell lung cancer in Japan: An interrupted time series study	18
Phospholipid metabolic adaptation promotes survival of IDH2 mutant acute myeloid leukemia cells	18
Real‐World Comparison of Gene‐Matched vs. Non‐Gene‐Matched Therapy Outcomes Using Integrated Genomic and Clinical Data	18
PD‐1 blockade treatment in melanoma: Mechanism of response and tumor‐intrinsic resistance	18
ELF1 suppresses autophagy to reduce cisplatin resistance via the miR‐152‐3p/NCAM1/ERK axis in lung cancer cells	18
Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leukemia	18
Novel Methylation‐Based Model for Accurate Diagnosis of Upper Mediastinal Lymph Node Metastasis in Esophagogastric Junction Adenocarcinoma	18
A YAP / TAZ – CDC6 Axis Initiates and Maintains	18
Metabolic stress‐induced reciprocal loop of long noncoding RNA ZFAS1 and ZEB1 promotes epithelial–mesenchymal transition and metastasis of pancreatic cancer cells	18
MED27 plays a tumor‐promoting role in breast cancer progression by targeting KLF4	18
Ligand‐Based CAR‐T Cells Targeting EGFR Exhibit Favorable Antitumor Effects Against Gynecologic Malignancies	18
ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN‐Amplified Neuroblastoma	18
Issue Information	18
Targeting Inflammation and Immune Regulation in Chronic Inflammation Associated Cancers	18
SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling	18
Elotuzumab‐mediated ADCC with Th1‐like Vγ9Vδ2 T cells to disrupt myeloma–osteoclast interaction	18
Tertiary lymphoid structure and neutrophil–lymphocyte ratio coordinately predict outcome of pembrolizumab	18
The Black Hole of Immune Checkpoint Blocking Therapy for Gastric Cancer: Hyperprogressive Disease	18
Connexin43 Promotes the Invasion and Metastasis of Lung Squamous Cell Carcinoma via GJIC‐Dependent Ca²⁺/ERK Signaling Activation	18
Circular RNA circARHGEF28 inhibited the progression of prostate cancer via the miR‐671‐5p/LGALS3BP/NF‐κB axis	18
Neutrophil‐Macrophage Interactions Shape Inflammatory Macrophage Remodeling in Gastric Cancer During Chemo‐Immunotherapy	18
Extensive analysis of 59 sarcoma‐related fusion genes identified pazopanib as a potential inhibitor to COL1A1‐PDGFB fusion gene	17
Serum untargeted metabolomics reveal metabolic alteration of non‐small cell lung cancer and refine disease detection	17
Characterization and clinical implications of different malignant transformation patterns in diffuse low‐grade gliomas	17
ZNF500 abolishes breast cancer proliferation and sensitizes chemotherapy by stabilizing P53 via competing with MDM2	17
Authors' Reply to Letter to the Editor: Sequential Ramucirumab Plus Docetaxel After PD ‐1 Inhibitors	17
STAT3 regulates 5‐Fu resistance in human colorectal cancer cells by promoting Mcl‐1–dependent cytoprotective autophagy	17
A combination of lymphatic drug delivery of anti‐CTLA‐4 antibody and local radiotherapy for solid‐tumor treatment	17
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort	17
Transporter‐Associated Therapeutic Efficacy of an SMVT ‐Targeted Boron Carrier in Boron Neutron Capture Therapy	17
Realizing Equitable Precision Oncology via Remote Participation: Japan's First Fully Decentralized Trial ( WJOG15221M )	17
Senescence and senolysis in cancer: The latest findings	17
MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma	17
Identification and validation of a poor clinical outcome subtype of primary prostate cancer with Midkine abundance	17
Senescent CD8⁺ T cells acquire NK cell‐like innate functions to promote antitumor immunity	17
Single‐cell transcriptomic analysis of gingivo‐buccal oral cancer reveals two dominant cellular programs	17
A Nationwide Central Diagnosis for Pediatric CNS Tumors in Japan: The JCCG Brain Tumor and Pathology Committees	17
Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice	17
Pan‐immune‐inflammation value predicts immunotherapy response and reflects local antitumor immune response in rectal cancer	16
A Novel Method for Prognostic Risk Classification After Carbon‐Ion Radiotherapy for Hepatocellular Carcinoma Using Data‐Mining Methods	16
Second Opinion Referrals of Cancer Patients in Japan—A Nationwide Study	16
The LGALS9 / miR ‐491‐5p Axis Regulates CD8	16
CircBRD7 attenuates tumor growth and metastasis in nasopharyngeal carcinoma via epigenetic activation of its host gene	16
RETRACTION : MicroRNA ‐16 inhibits glioma cell growth and invasion through suppression of BCL	16
CALR / HIF ‐1α Positive Feedback Loop Drives CALR Upregulation to P	16
	16
	16
Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments	16
Immunological Heterogeneity in Gastric Cancer: Context‐Dependent Role of CD8 ⁺ T Cells	16
Metronomic chemotherapy for indolent T‐cell lymphoproliferative disorder of the gastrointestinal tract	16
Correction	16
The cancer epigenome: Non‐cell autonomous player in tumor immunity	16
lncDILC Downregulation in Liver Cancer‐Associated Fibroblasts Drives Pro‐Invasive Conversion via a miR ‐6071‐	16
Nationwide Real‐World Usage of Blood‐Based (Liquid) Biomarker Testing in Japan	16
Adaptive use of error‐prone DNA polymerases provides flexibility in genome replication during tumorigenesis	16
Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia	16
Spatial omics technologies for understanding molecular status associated with cancer progression	16
Novel TEAD1 Inhibitor VT103 Enhances Dabrafenib Efficacy in BRAFV600E Mutated Lung Adenocarcinoma via Survivin Downregulation	16
Correction to “Upregulation of HLA ‐ II Related to LAG	16
Correction to “Long noncoding RNA SNHG3 interacts with microRNA‐502‐3p to mediate ITGA6 expression in liver hepatocellular carcinoma”	16
p53 Arg72Pro polymorphism, adiposity status, and cancer risk: Two case‐cohorts within a Japanese prospective study	16
Fat and proteolysis due to methionine, tryptophan, and niacin deficiency leads to alterations in gut microbiota and immune modulation in inflammatory bowel disease	15
Cancer cell‐derived exosomal miR‐20a‐5p inhibits CD8⁺ T‐cell function and confers anti‐programmed cell death 1 therapy resistance in triple‐negative breast	15
Patient survey on cancer genomic medicine in Japan under the national health insurance system	15
SLPI / FBW7 /c‐Myc Axis Reduces Gemcitabine Sensitivity in PDAC by	15
Alvocidib inhibits IRF4 expression via super‐enhancer suppression and adult T‐cell leukemia/lymphoma cell growth	15
Trends in patterns of treatment and survival of colorectal cancer patients using cancer registry data in Japan: 1995–2015	15
Noncanonical TCA cycle fosters canonical TCA cycle and mitochondrial integrity in acute myeloid leukemia	15
MEN1 deficiency stabilizes PD‐L1 and promotes tumor immune evasion of lung cancer	15
circEZH2^E2^/E3 is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression	15
Novel positron emission tomography imaging targeting cell surface glycans for pancreatic cancer: ¹⁸F‐labeled rBC2LCN lectin	15
Issue Information	15
AXL‐Mediated Drug Resistance in ALK‐Rearranged NSCLC Enhanced by GAS6 From Macrophages and MMP11 Positive Fibroblasts	15
Cross‐talk between gastric cancer and hepatic stellate cells promotes invadopodia formation during liver metastasis	15
Circadian clock protein Bmal1 accelerates acute myeloid leukemia by inhibiting ferroptosis through the EBF3/ALOX15 axis	15
Relationships between physical and immunological tumor microenvironment in pancreatic ductal adenocarcinoma	15
Dual targeted therapy with pyrotinib and trastuzumab forHER2‐positive advanced colorectal cancer: A phase 2 trial	15
Importance of SUMOylation Consensus Sequence of MAFK in Regulating EMT	15
Newly developed humanized anti‐CKAP4 antibody suppresses pancreatic cancer growth by inhibiting DKK1‐CKAP4 signaling	15
Afatinib Versus Osimertinib for Non‐Small Cell Lung Cancer With Uncommon EGFR Mutations: Real‐World Outcomes	15
Multiomics analyses and machine learning of nuclear receptor coactivator 6 reveal its essential role in hepatocellular carcinoma	14
Opportunities to Modulate Tumor Ecosystem Toward Successful Glioblastoma Immunotherapy	14
Durvalumab Post Concurrent Chemoradiotherapy in Japanese Patients With Limited‐Stage Small‐Cell Lung Cancer in the Phase 3 ADRIATIC Trial	14
	14